Ciulla Thomas 4
4 · Clearside Biomedical, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Ciulla Thomas
Chief Medical Officer
Transactions
- Award
Common Stock
2022-06-30$1.25/sh+5,000$6,250→ 302,760 total - Award
Employee Stock Option (right to buy)
2023-01-04+187,500→ 187,500 totalExercise: $1.48Exp: 2033-01-04→ Common Stock (187,500 underlying) - Award
Common Stock
2022-12-31$0.95/sh+5,000$4,750→ 307,760 total
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]One-fourth of the shares underlying this option vest on January 4, 2024 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.